CI

At a glance

ClinicalIndex Comparison Record
N/ARecruiting· 5,000 target
Drug / intervention
Not specified
Likely dose
Not stated in record
Key inclusion· 5
  • ✓Newly-diagnosed colon or rectal cancer stages I-IV
  • ✓Age 18-89 years; 18-69 years for patients recruited after 09/01/2021
  • ✓Men and women
  • ✓English or German-speaking depending on site
Key exclusion· 1
  • ✕Insufficient language or consent capacity

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02328677
NCT02328677N/ARecruitingHigh MomentumUpdated 12mo ago
Long Recruiting
CompareCT.gov

ColoCare Transdisciplinary Research in Colorectal Cancer Prognosis

University of Utah·observational·Posted Dec 31, 2014·Updated Jun 13, 2025

In Brief

An observational study for Colorectal Cancer. Currently recruiting, targeting 5,000 participants across 7 sites in 2 countries.

Signals

Enrolling ahead of pace

Detailed Summary

ColoCare is an international prospective cohort study of stage I-IV colorectal cancer patients (ICD-10 C18-C20).

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsColorectal Cancer
CountriesGermany, United States
CollaboratorsGerman Cancer Research Center, H. Lee Moffitt Cancer Center and Research Institute, Huntsman Cancer Institute, Cedars-Sinai Medical Center, Washington University School of Medicine, University of Tennessee

Timeline

N/ARecruiting
2007200820092010201120122013201420152016201720182019202020212022202320242025202620272028202920302031
First PostedDec 31, 2014
Enrollment StartMar 1, 2007
Primary CompletionOct 1, 2030
TodayJul 2, 2026
Enrollment to primary: 23.6 yearsPosted 11.5 years agoPrimary completion in 4.2 years